Cell lines from MYCN transgenic murine tumours reflect the molecular and biological characteristics of human neuroblastoma

A.J. Cheng, N. Ching Cheng, J. Ford, J. Smith, J.E. Murray, C. Flemming, M. Lastowska, M.S. Jackson, C.S. Hackett, W.A. Weiss, G.M. Marshall, Ursula Kees, M.D. Norris, M. Haber

Research output: Contribution to journalArticlepeer-review

34 Citations (Scopus)

Abstract

Overexpression of the human MYCN oncogene driven by a tyrosine hydroxylase promoter causes tumours in transgenic mice that recapitulate the childhood cancer neuroblastoma. To establish an in vitro model to study this process, a series of isogenic cell lines were developed from these MYCN-driven murine tumours. Lines were established from tumours arising in homozygous and hemizygous MYCN transgenic mice. Hemizygous tumours gave rise to cell lines growing only in suspension. Homozygous tumours gave rise to similar suspension lines as well as morphologically distinct substrate-adherent lines characteristic of human S-type neuroblastoma cells. FISH analysis demonstrated selective MYCN transgene amplification in cell lines derived from hemizygous mice. Comparative genomic hybridisation (CGH) and fluorescence in situ hybridisation (FISH) analysis confirmed a range of neuroblastoma-associated genetic changes in the various lines, in particular, gain of regions syntenic with human 17q. These isogenic lines together with the transgenic mice thus represent valuable models for investigating the biological characteristics of aggressive neuroblastoma.
Original languageEnglish
Pages (from-to)1467-1475
JournalEuropean Journal of Cancer
Volume43
Issue number9
DOIs
Publication statusPublished - 2007

Fingerprint

Dive into the research topics of 'Cell lines from MYCN transgenic murine tumours reflect the molecular and biological characteristics of human neuroblastoma'. Together they form a unique fingerprint.

Cite this